Cargando…
Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials
WHAT IS KNOWN AND OBJECTIVE: Edaravone is a new antioxidant and hydroxyl radical scavenger. Although there is evidence that it improves clinical outcomes of patients with acute ischaemic stroke (AIS), it is not yet widely accepted for treatment of AIS in Western countries. We further investigated th...
Autores principales: | Chen, Chongyue, Li, Mingkai, Lin, Liling, Chen, Shuying, Chen, Yongru, Hong, Liekai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359409/ https://www.ncbi.nlm.nih.gov/pubmed/33638896 http://dx.doi.org/10.1111/jcpt.13392 |
Ejemplares similares
-
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
por: Xu, Jie, et al.
Publicado: (2019) -
Safety and efficacy of edaravone for patients with acute stroke: A protocol for randomized clinical trial
por: Shan, Hailei, et al.
Publicado: (2021) -
Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study
por: Yang, Hui-qin, et al.
Publicado: (2022) -
A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
por: Sharma, Pawan, et al.
Publicado: (2011) -
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)